BioWorld Asia

Oct. 5, 2005

Scientists Probe Signature' Of Cancer Genetic Damage

NatImmune, Enzon Enter Deal On Recombinant MBL

Closing In On First Revenues, Phoqus Seeking IPO On Aim

MMI Raises £10M For Genvax's Clinical Studies Of Vaccines

Other News To Note

Karo Bio Seeking SEK280M In Discounted Rights Issue

Karo Bio AB is seeking SEK280 million (US$35.9 million) in a discounted rights issue to fund its switch from early stage discovery to clinical development. (BioWorld International) Read More

SkyePharma Raising Funds After Scuttled Partner Deal

Today's news in brief

BioWorld

BioWorld briefs for June 23, 2026.

Alicorn synthesizes new AAK1 inhibitors

BioWorld Science

Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 23, 2026

Have brain-computer interfaces finally arrived?

BioWorld

More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...

Nankai University and Accendatech present new majusculamide D derivatives

BioWorld Science

Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...